Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

about

Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Co-Administered with Measles, Yellow Fever and Meningitis A Vaccines in 9-month-old Malian Infants.

P2860

Q53829816-C5158914-D395-49B0-B29C-488DA4F968E3

P2860

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

Item

http://www.wikidata.org/entity/Q47422430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@en

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@nl

type

Item

label

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@en

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@nl

prefLabel

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@en

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@nl

P1476

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

@en

P2093

Eleanor Burnett

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.

Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013.

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial.

Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016.

Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.

Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study.

Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.

Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.

P304

7198-7203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2017.10.027

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Benjamin Lopman

Umesh D Parashar

P577

2017-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29169893

http://www.w3.org/2001/XMLSchema#string

P921

Afọ ọsịsa

P932

5841463

http://www.w3.org/2001/XMLSchema#string

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

about

P2860

P2860

Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932